Cargando…
Corrigendum: A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy
Autores principales: | Bari, Rafijul, Granzin, Markus, Tsang, Kam Sze, Roy, Andre, Krueger, Winfried, Orentas, Rimas, Schneider, Dina, Pfeifer, Rita, Moeker, Nina, Verhoeyen, Els, Dropulic, Boro, Leung, Wing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905181/ https://www.ncbi.nlm.nih.gov/pubmed/31839796 http://dx.doi.org/10.3389/fimmu.2019.02784 |
Ejemplares similares
-
A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy
por: Bari, Rafijul, et al.
Publicado: (2019) -
Reference standards for accurate validation and optimization of assays that determine integrated lentiviral vector copy number in transduced cells
por: Paugh, Barbara S., et al.
Publicado: (2021) -
A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines
por: Schneider, Dina, et al.
Publicado: (2017) -
Minimizing leukemia escape: implementing a dual anti-CD20- and CD19-scFv-based chimeric antigen receptor (CAR)
por: Schneider, Dina, et al.
Publicado: (2015) -
Advances in Lentiviral Vector-based Cell Therapy with Mesenchymal Stem Cells
por: Baranyi, Lajos, et al.
Publicado: (2012)